triple agonist glp-1 Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data retatrutide mechanism triple agonist gip

However, individuals with pre-existing eye conditions or vascular risk factors should be particularly cautious

GLP-1 agonist drugs, which are synthetic versions of the naturally occurring GLP-1 hormone, have been used for decades in the treatment and management of Type II Diabetes Mellitus (T2DM)

This is simply because Ozempic drug trials focused on how it impacted blood sugar (like metformin does), while Wegovy drug trials focused on how it impacted weight

Secondary outcomes demonstrated significant improvements in metabolic parameters

[Google Scholar] [22].Yang XD, Yang YY

Am J Physiol Regul Integr Comp Physiol 299 , R945952, (2010)